View More View Less
  • 1 Flór Ferenc County Hospital Kistarcsa Hungary
  • | 2 KRKA Hungary Ltd. Budapest Hungary
  • | 3 Flór Ferenc County Hospital Semmelweis tér 1 H-2143 Kistarcsa Hungary
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $752.00

  • Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS: ACC/AHA 2007 Guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. J. Am. Coll. Cardiol. 50, 1–157 (2007)

    Wright R.S. , 'ACC/AHA 2007 Guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction ' (2007 ) 50 J. Am. Coll. Cardiol. : 1 -157.

    • Search Google Scholar
  • Antaloczy Z, Barcsák J, Magyar E: Correlation of electrocardiologic and pathologic findings in 100 cases of Q wave and non-Q wave myocardial infarction. J. Electrocardiol. 21, 331–335 (1988)

    Magyar E. , 'Correlation of electrocardiologic and pathologic findings in 100 cases of Q wave and non-Q wave myocardial infarction ' (1988 ) 21 J. Electrocardiol. : 331 -335.

    • Search Google Scholar
  • Athyros VG, Papageorgiou AA, Mercouris BR, Athyrou VV, Symeonidis AN, Basayannis EO, Demitriadis DS, Kontopoulos AG: Treatment with atorvastatin to the National Cholesterol Educational Program goal versus ‘usual’ care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. Curr. Med. Res. Opin. 18, 220–228 (2002)

    Kontopoulos A.G. , 'Treatment with atorvastatin to the National Cholesterol Educational Program goal versus ‘usual’ care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study ' (2002 ) 18 Curr. Med. Res. Opin. : 220 -228.

    • Search Google Scholar
  • Authors/Task Force Members, Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernandez-Aviles F, Fox KAA, Hasdai D, Ohman EM, Wallentin L, Wijns W: Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur. Heart. J. 28, 1598–1660 (2007)

    Wijns W. , 'Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes ' (2007 ) 28 Eur. Heart. J. : 1598 -1660.

    • Search Google Scholar
  • Banyai S, Banyai M, Falger J, Jansen M, Alt E, Derfler K, Koppensteiner R: Atorvastatin improves blood rheology in patients with familial hypercholesterolemia (FH) on long-term LDL apheresis treatment. Atherosclerosis 159, 513–519 (2001)

    Koppensteiner R. , 'Atorvastatin improves blood rheology in patients with familial hypercholesterolemia (FH) on long-term LDL apheresis treatment ' (2001 ) 159 Atherosclerosis : 513 -519.

    • Search Google Scholar
  • Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE 3rd, Steward DE, Theroux P, Gibbons RJ, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Smith SC Jr: ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. J. Am. Coll. Cardiol. 40, 1366–1374 (2002)

    Smith S.C. , 'ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction ' (2002 ) 40 J. Am. Coll. Cardiol. : 1366 -1374.

    • Search Google Scholar
  • Brush JE Jr, Cannon RO 3rd, Schenke Wh, Bonow RO, Leon MB, Maron BJ, Epstein SE: Angina due to microvascular disease in hypertensive patients without left ventricular hypertrophy. N. Eng. J. Med. 319, 1302–1307 (1988)

    Epstein S.E. , 'Angina due to microvascular disease in hypertensive patients without left ventricular hypertrophy ' (1988 ) 319 N. Eng. J. Med. : 1302 -1307.

    • Search Google Scholar
  • Budaj A, Yusuf S, Mehta S, Fox K, Tognoni G, Zhao F, Chrolavicius S, Hunt D, Keltai M, Franzosi: for the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Trial Investigators. Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups. Circulation 10, 1622–1626 (2002)

    Franzosi , 'Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups ' (2002 ) 10 Circulation : 1622 -1626.

    • Search Google Scholar
  • Camici PG, Crea F: Medical progress: coronary microvascular dysfunction. N. Eng. J. Med. 356, 830–840 (2007)

    Crea F. , 'Medical progress: coronary microvascular dysfunction ' (2007 ) 356 N. Eng. J. Med. : 830 -840.

    • Search Google Scholar
  • Cannon RO, Epstein SE: “Microvascular angina” as a cause of chest pain with angiographically normal coronary arteries. Am. J. Cardiol. 61, 1338–1343 (1988)

    Epstein S.E. , '“Microvascular angina” as a cause of chest pain with angiographically normal coronary arteries ' (1988 ) 61 Am. J. Cardiol. : 1338 -1343.

    • Search Google Scholar
  • Crea F, Lanza GA: Angina pectoris and normal coronary arteries: cardiac syndrome X. Heart 90, 457–463 (2004)

    Lanza G.A. , 'Angina pectoris and normal coronary arteries: cardiac syndrome X ' (2004 ) 90 Heart : 457 -463.

    • Search Google Scholar
  • de Lemos JA, Blazing MA, Wiviott SD, Lewis EF, Fox KA, White HD, Rouleau JL, Pedersen TR, Gardner LH, Mukherjee R, Ramsey KE, Palmisano J, Bilheimer DW, Pfeffer MA, Califf RM, Braunwald E: A to Z Investigators. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA 292, 1307–1316 (2004)

    Braunwald E. , 'A to Z Investigators. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial ' (2004 ) 292 JAMA : 1307 -1316.

    • Search Google Scholar
  • Deanfield JE, Detry JM, Sellier P, Lichtlen PR, Thaulow E, Bultas J, Brennan C, Young ST, Beckerman B: CAPE II Trial Investigators. Medical treatment of myocardial ischemia in coronary artery disease: effect of drug regime and irregular dosing in the CAPE II trial. J. Am. Coll. Cardiol. 40, 917–925 (2002)

    Beckerman B. , 'CAPE II Trial Investigators. Medical treatment of myocardial ischemia in coronary artery disease: effect of drug regime and irregular dosing in the CAPE II trial ' (2002 ) 40 J. Am. Coll. Cardiol. : 917 -925.

    • Search Google Scholar
  • Di Stefano R, Di Bello V, Barsotti MC, Grigoratos C, Armani C, Dell’Omodarme M, Carpi A, Balbarini A.: Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models. Biomed. Pharmacother. 63(10), 773–780 (2009)

    Balbarini A. , 'Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models ' (2009 ) 63 Biomed. Pharmacother. : 773 -780.

    • Search Google Scholar
  • Dujovne CA, Harris WS, Altman R, Overhiser RW, Black DM: Effect of atorvastatin on hemorheologic-hemostatic parameters and serum fibrinogen levels in hyperlipidemic patients. Am. J. Cardiol. 85, 350–353 (2000)

    Black D.M. , 'Effect of atorvastatin on hemorheologic-hemostatic parameters and serum fibrinogen levels in hyperlipidemic patients ' (2000 ) 85 Am. J. Cardiol. : 350 -353.

    • Search Google Scholar
  • Ernst E, Hammerschmidt DE, Bagge U, Matrai A, Dormandy JA: Leukocytes and the risk of ischemic heart diseases. JAMA, 257, 2318–2324 (1987)

    Dormandy J.A. , 'Leukocytes and the risk of ischemic heart diseases ' (1987 ) 257 JAMA : 2318 -2324.

    • Search Google Scholar
  • Fox K, Ford I, Steg PG, Tendera M, Ferrari: On behalf of the BEAUTIFUL. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomized, double-blind, placebo-controlled trial. Lancet DOI:10.1016/S0140-6736(08)61170-8 (2008)

  • Fox KM: EURopean trial on reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 362, 782–788 (2003)

    Fox K.M. , 'EURopean trial on reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) ' (2003 ) 362 Lancet : 782 -788.

    • Search Google Scholar
  • Jorgensen B, Simonsen S, Endresen K, Forfang K, Vatne K, Hansen J, Webb J, Buller C, Goulet G, Erikssen J, Thaulow E: Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the Coronary AngioPlasty Amlodipine REStenosis Study (CAPARES). J. Am. Coll. Cardiol. 35, 592–599 (2000)

    Thaulow E. , 'Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the Coronary AngioPlasty Amlodipine REStenosis Study (CAPARES) ' (2000 ) 35 J. Am. Coll. Cardiol. : 592 -599.

    • Search Google Scholar
  • Kobaladze SG, Tschikvadze IV: The use of pentoxiphyllin in the treatment of ischemic heart disease. Current Medical Research and Opinion 6(s4), 12–14 (1979)

    Tschikvadze I.V. , 'The use of pentoxiphyllin in the treatment of ischemic heart disease ' (1979 ) 6 Current Medical Research and Opinion : 12 -14.

    • Search Google Scholar
  • LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, Gotto AM, Greten H, Kastelein JJ, Shepherd J, Wenger NK: Treating to New Targets (TNT) Investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N. Engl. J. Med. 352, 1425–1435 (2005)

    Wenger N.K. , 'Treating to New Targets (TNT) Investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary disease ' (2005 ) 352 N. Engl. J. Med. : 1425 -1435.

    • Search Google Scholar
  • Lauer MA, Houghtaling PI, Peterson JG, Granger CB, Bhatt DL, Sapp SK, Simoons ML, Harrington RA, Topol EJ, Lincoft A: and Platelet IIb/IIIa in Unstable Angina Receptor Suppression Using Integrilin Therapy (PURSUIT) trial investigators. Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acute coronary syndromes: observations from the Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trial. Circulation 104, 2772–2777 (2001)

    Lincoft A. , 'Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acute coronary syndromes: observations from the Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trial ' (2001 ) 104 Circulation : 2772 -2777.

    • Search Google Scholar
  • Lerman A, Holmes DR, Herrmann J, Gersch BJ: Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both? Eur. Heart. J. Advance doi:10.1093/eurheartj/ehl501 Access published online on March 8, (2007)

  • Lowe G, Rumley A, Norrie J, Ford I, Shepherd J, Cobbe S, Macfarlane P, Packard C: Blood rheology, cardiovascular risk factors, and cardiovascular disease: The West of Scotland Coronary Prevention Study. Thromb. Haemost. 84, 533–538 (2000)

    Packard C. , 'Blood rheology, cardiovascular risk factors, and cardiovascular disease: The West of Scotland Coronary Prevention Study ' (2000 ) 84 Thromb. Haemost. : 533 -538.

    • Search Google Scholar
  • Marcus ML, Chilian WM, Kanatsuka H, Dellsperger KC, Eastham CL, Lamping KG: Understanding the coronary circulation through studies at microvascular level. Circulation 82, 1–7 (1990)

    Lamping K.G. , 'Understanding the coronary circulation through studies at microvascular level ' (1990 ) 82 Circulation : 1 -7.

    • Search Google Scholar
  • Marzilli M, Focardi M, Sambuceti G (2006): Microvascular function before and after coronary recanalization. In: The paradox of angina persisting after coronary revascularization. Ed.: Marzilli M, Paris, France: Elsevier, pp. 41–51

    Sambuceti G. , '', in The paradox of angina persisting after coronary revascularization , (2006 ) -.

  • Marzilli M, Sambuceti G, Fedele S, L’Abbate A: Coronary microcirculatory vasoconstriction during ischemia in patients with unstable angina. J. Am. Coll. Cardiol. 35, 327–334 (2000)

    L’Abbate A. , 'Coronary microcirculatory vasoconstriction during ischemia in patients with unstable angina ' (2000 ) 35 J. Am. Coll. Cardiol. : 327 -334.

    • Search Google Scholar
  • Medvegy M, Savard P, Pintér A, Tremblay G, Nasmith JB, Palisaitis D., Duray G, Préda I, Nadeau RA: Simple, quantitative body surface potential map parameters in the diagnosis of remote Q-wave and non-Q-wave myocardial infarction. Can. J. Cardiol 20, 1109–1115 (2004)

    Nadeau R.A. , 'Simple, quantitative body surface potential map parameters in the diagnosis of remote Q-wave and non-Q-wave myocardial infarction ' (2004 ) 20 Can. J. Cardiol : 1109 -1115.

    • Search Google Scholar
  • Medvegy M, Nadeau RA, Szűcs E, Szakolczai K, Simonyi G, Bauernfeind T, Szedlák M, Savard P, Palisaitis D, Préda I: Diagnosis and discrimination of remote antero- and inferoseptal non-Q wave myocardial infarctions with body surface potential mapping. Can. J. Cardiol 24, 53–55 (2008)

    Préda I. , 'Diagnosis and discrimination of remote antero- and inferoseptal non-Q wave myocardial infarctions with body surface potential mapping ' (2008 ) 24 Can. J. Cardiol : 53 -55.

    • Search Google Scholar
  • Medvegy M, Préda I, Savard P, Pintér A, Tremblay G, Nasmith J, Palisaitis D, Nadeau RA: A new body surface isopotential map evaluation method to detect minor potential losses in non-Q wave myocardial infarction. Circulation 101, 1115–1121 (2000)

    Nadeau R.A. , 'A new body surface isopotential map evaluation method to detect minor potential losses in non-Q wave myocardial infarction ' (2000 ) 101 Circulation : 1115 -1121.

    • Search Google Scholar
  • Montalescot G, Dallongeville J, Van Belle E, Rouanet S, Baulac C, Degrandsart A, Vicaut E: STEMI and NSTEMI: are they so different? 1-year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the Opera registry). Eur. Heart J. 28, 1409–1417 (2007)

    Vicaut E. , 'STEMI and NSTEMI: are they so different? 1-year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the Opera registry) ' (2007 ) 28 Eur. Heart J. : 1409 -1417.

    • Search Google Scholar
  • Nissen SE, Tuzcu EM, Libby P, Thompson PD, Ghali M, Garza D, Berman L, Shi H, Buebendorf E, Topol EJ: CAMELOT Investigators. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA 292, 2217–2225 (2004)

    Topol E.J. , 'Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial ' (2004 ) 292 JAMA : 2217 -2225.

    • Search Google Scholar
  • Pasqui AL, Di Renzo M, Bova G, Bruni F, Puccetti L, Pompella G, Auteri A: T cell activation and enhanced apoptosis in non-ST elevation myocardial infarction. Clinical and Experimental Medicine 3, 37–44 (2003)

    Auteri A. , 'T cell activation and enhanced apoptosis in non-ST elevation myocardial infarction ' (2003 ) 3 Clinical and Experimental Medicine : 37 -44.

    • Search Google Scholar
  • Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL, Blankensteijn JD, Baars HF, Yo TI, Trocino G, Vigna C, Roelandt JR, van Urk H: The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. New Engl. J. Med. 341, 1789–1794 (1999)

    Urk H. , 'The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group ' (1999 ) 341 New Engl. J. Med. : 1789 -1794.

    • Search Google Scholar
  • Rosenson RS: Statin therapy: new therapy for cardiac microvascular dysfunction. Eur. Heart J. 24, 1993–1994 (2003)

    Rosenson R.S. , 'Statin therapy: new therapy for cardiac microvascular dysfunction ' (2003 ) 24 Eur. Heart J. : 1993 -1994.

    • Search Google Scholar
  • Rott D, Leibowitz D: STEMI and NSTEMI are two distinct pathophysiological entities. Eur. Heart J. 28, 2685 (2007)

    Leibowitz D. , 'STEMI and NSTEMI are two distinct pathophysiological entities ' (2007 ) 28 Eur. Heart J. : 2685 -.

    • Search Google Scholar
  • Rubio R, Berne RM: Regulation of coronary blood flow. Prog. Cardiovasc. Dis. 18, 105–136 (1975)

    Berne R.M. , 'Regulation of coronary blood flow ' (1975 ) 18 Prog. Cardiovasc. Dis. : 105 -136.

    • Search Google Scholar
  • Sambuceti G, Marzilli M, Fedele S, Marini C, L’Abbate A: Paradoxical increase in microvascular resistance during tachycardia downstream from a severe stenosis in patients with coronary artery disease: reversal by angioplasty. Circulation 103, 2352–2360 (2001)

    L’Abbate A. , 'Paradoxical increase in microvascular resistance during tachycardia downstream from a severe stenosis in patients with coronary artery disease: reversal by angioplasty ' (2001 ) 103 Circulation : 2352 -2360.

    • Search Google Scholar
  • Sambuceti G, Marzilli M, Mari A, Marini C, Schluter M, Testa R, Papini M, Marraccini P, Ciriello G, Marzullo P, L’Abbate A: Coronary microcirculatory vasoconstriction is heterogeneously distributed in acutely ischemic myocardium. Am. J. Physiol. Heart Circ. Physiol. 288, H2298–H2305 (2005)

    L’Abbate A. , 'Coronary microcirculatory vasoconstriction is heterogeneously distributed in acutely ischemic myocardium ' (2005 ) 288 Am. J. Physiol. Heart Circ. Physiol. : H2298 -H2305.

    • Search Google Scholar
  • Sato H, Iida H, Tanaka A, Tanaka H, Shimodouzono S, Uchida E, Kawarabayashi T, Yoshikawa J: The decrease of plaque volume during percutaneous coronary intervention has a negative impact coronary flow in acute myocardial infarction: a major role of percutaneous coronary intervention-induced embolization. J. Am. Coll. Cardiol. 44, 300–304 (2004)

    Yoshikawa J. , 'The decrease of plaque volume during percutaneous coronary intervention has a negative impact coronary flow in acute myocardial infarction: a major role of percutaneous coronary intervention-induced embolization ' (2004 ) 44 J. Am. Coll. Cardiol. : 300 -304.

    • Search Google Scholar
  • Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, Zeiher A, Chaitman BR, Leslie S, Stern T: Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 285, 1711–1718 (2001)

    Stern T. , 'Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial ' (2001 ) 285 JAMA : 1711 -1718.

    • Search Google Scholar
  • Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Meinders AE, Norrie J, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG: PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360, 1623–1630 (2002)

    Westendorp R.G. , 'PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial ' (2002 ) 360 Lancet : 1623 -1630.

    • Search Google Scholar
  • Steen H, Giannitsis E, Futterer S, Merten C, Juenger C, Katus HA: Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function. J. Am. Coll. Cardiol. doi:10.1016/j.jacc.2006.06.002 published online Nov 8 (2006)

  • Stenestrand U, Wallentin L: for the Swedish Register of Cardiac Intensive Care (RIKS-HIA). Register of Information and Knowledge About Swedish Heart Intensive Care Admissions. JAMA 285, 430–436 (2001)

    Wallentin L. , 'Register of Information and Knowledge About Swedish Heart Intensive Care Admissions ' (2001 ) 285 JAMA : 430 -436.

    • Search Google Scholar
  • Sweetnam PM, Thomas HF, Yarnell JWG, Beswick AD, Baker IA, Elwood PC: Fibrinogen, viscosity and the 10-year incidence of ischemic heart disease. Eur. Heart J. 17, 1814–1820 (1996)

    Elwood P.C. , 'Fibrinogen, viscosity and the 10-year incidence of ischemic heart disease ' (1996 ) 17 Eur. Heart J. : 1814 -1820.

    • Search Google Scholar
  • Szűcs E, Szakolczai K, Simonyi G, Bauernfeind T, Pintér A, Préda I, Medvegy M: Diagnostic value of body surface potential mapping in assessment of the coronary artery lesion after angina pectoris and without repolarization changes on the ECG. J. Electrocardiol. 49(4), 326–335 (2010)

    Medvegy M. , 'Diagnostic value of body surface potential mapping in assessment of the coronary artery lesion after angina pectoris and without repolarization changes on the ECG ' (2010 ) 49 J. Electrocardiol. : 326 -335.

    • Search Google Scholar
  • TIMI III-B Investigators: Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q wave myocardial infarction: results of the TIMI IIIB trial. Thrombolysis In Myocardial Ischaemia. Circulation 89, 1545–1556 (1994)

    'Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q wave myocardial infarction: results of the TIMI IIIB trial. Thrombolysis In Myocardial Ischaemia ' (1994 ) 89 Circulation : 1545 -1556.

    • Search Google Scholar
  • Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. New Eng. J. Med. 342, 145–153 (2000)

    Dagenais G. , 'Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators ' (2000 ) 342 New Eng. J. Med. : 145 -153.

    • Search Google Scholar

The author instruction is available in PDF.

Please, download the file from HERE

Senior editors

Editor(s)-in-Chief: Rosivall, László

Honorary Editor(s)-in-Chief): Monos, Emil

Managing Editor(s): Bartha, Jenő; Berhidi, Anna

Co-editor(s): Koller, Ákos; Lénárd, László; Szénási, Gábor

Assistant Editor(s): G. Dörnyei (Budapest), Zs. Miklós (Budapest), Gy. Nádasy (Budapest)

Hungarian Editorial Board

    1. Benedek, György (Szeged)
    1. Benyó, Zoltán (Budapest)
    1. Boros, Mihály (Szeged)
    1. Chernoch, László (Debrecen)
    1. Détári, László (Budapest)
    1. Hamar, János (Budapest)
    1. Hantos, Zoltán (Szeged)
    1. Hunyady, László (Budapest)
    1. Imre, Sándor (Debrecen)
    1. Jancsó, Gábor (Szeged)
    1. Karádi, Zoltán (Pécs)
    1. Kovács, László (Debrecen)
    1. Palkovits, Miklós (Budapest)
    1. Papp, Gyula (Szeged)
    1. Pavlik, Gábor (Budapest)
    1. Spät, András (Budapest)
    1. Szabó, Gyula (Szeged)
    1. Szelényi, Zoltán (Pécs)
    1. Szolcsányi, János (Pécs)
    1. Szollár, Lajos (Budapest)
    1. Szücs, Géza (Debrecen)
    1. Telegdy, Gyula (Szeged)
    1. Toldi, József (Szeged)
    1. Tósaki, Árpád (Debrecen)

International Editorial Board

    1. R. Bauer (Jena)
    1. W. Benjelloun (Rabat)
    1. A. W. Cowley Jr. (Milwaukee)
    1. D. Djuric (Belgrade)
    1. C. Fry (London)
    1. S. Greenwald (London)
    1. O. Hänninen (Kuopio)
    1. H. G. Hinghofer-Szalkay (Graz)
    1. Th. Kenner (Graz)
    1. Gy. Kunos (Richmond)
    1. M. Mahmoudian (Tehran)
    1. T. Mano (Seki, Gifu)
    1. G. Navar (New Orleans)
    1. H. Nishino (Nagoya)
    1. O. Petersen (Liverpool)
    1. U. Pohl (Münich)
    1. R. S. Reneman (Maastricht)
    1. A. Romanovsky (Phoenix)
    1. G. M. Rubanyi (Richmond)
    1. T. Sakata (Oita)
    1. A. Siddiqui (Karachi)
    1. Cs. Szabo (Beverly)
    1. E. Vicaut (Paris)
    1. N. Westerhof (Amsterdam)
    1. L. F. Zhang (Xi'an)

Editorial Office:
Akadémiai Kiadó Zrt.
Prielle Kornélia u. 21–35, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Physiologica Hungarica
Semmelweis University, Faculty of Medicine Institute of Pathophysiology
Nagyvárad tér 4, H-1089 Budapest, Hungary
Phone/Fax: +36-1-2100-100
E-mail: aph@semmelweis-univ.hu

Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • EMBASE/Excerpta Medica
  • Global Health
  • Index Copernicus
  • Index Medicus
  • Medline
  • Referativnyi Zhurnal
  • Science Citation Index Expanded
  • SCOPUS

 

Acta Physiologica Hungarica
Language English
Size  
Year of
Foundation
1950
Publication
Programme
changed title
Volumes
per Year
 
Issues
per Year
 
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 0231-424X (Print)
ISSN 1588-2683 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Jun 2021 10 0 0
Jul 2021 7 0 0
Aug 2021 35 1 0
Sep 2021 11 1 1
Oct 2021 26 0 0
Nov 2021 12 0 0
Dec 2021 0 0 0